18 Aug SkinGun™ Sprays Patient’s Own Stem Cells Onto Burns or Wounds To Accelerate Healing

MedicalResearch.com Interview with:

Thomas Bold

Thomas Bold
President and CEO
RenovaCare Inc.

MedicalResearch.com: What is the background for the CellMist™ System? How are the stem cells harvested and processed?

Response: Our flagship CellMist™ System makes use of a patient’s own stem cells, which are sprayed onto wounds using our novel SkinGun™ device.

For patients suffering severe burns and other wounds, the prospect of a quick-healing, gentle spray containing their own stem cells will be a promising alternative to conventional skin graft surgery, which can be painful, prone to complications like infections, and slow-to-heal.

Based on preliminary case studies, CellMist™ System patients can be treated within 90 minutes of arriving in an emergency room; a patient’s stem cells are isolated, processed, and sprayed on to the wound sites for rapid healing.

The CellMist™ Solution is a liquid suspension containing a patient’s own regenerative skin stem cells. A small sample (as small as a square inch) of the patient’s skin is quickly processed to liberate the stem cells from surrounding tissue. The resulting product is referred to as the ‘CellMist™ Solution’. The CellMist™ Solution is placed in the SkinGun™ and gently sprayed onto the patient’s wound.

MedicalResearch.com: What types of patients may benefit from this technology?

The SkinGun™ sprays patient’s own stem cells onto wound sites to begin healing.

Response: In investigative clinical use in the United States, SkinGun™ treatments have shown the potential to naturally and rapidly heal burns and other serious wounds. RenovaCare is developing the CellMist™ System as a promising new alternative for patients suffering from burns, chronic and acute wounds, and scars.

In the U.S. alone, this $45 billion market is greater than spending on high-blood pressure management, cholesterol treatments, and back pain therapeutics combined. Currently in investigational clinical use for second degree burn patients in the United States, the CellMist™ System targets an estimated 143 million patients worldwide who suffer burns, chronic and acute wounds, acne scarring, skin defects and diseases such as vitiligo (a skin discoloration condition, suffered by celebrities Michael Jackson and Jon Hamm).

According to the National Institutes of Health, skin disorders account for 40% of occupational-disease claims nationally.

MedicalResearch.com: What is unique at the SkinGun™ spray device? How does it facilitate the delivery of stem cells to a wound or burn?

Response: The SkinGun™ sprays the cells onto wound sites to begin healing. Unlike conventional aerosol and pump systems, the RenovaCare next-generation fluid sprayer does not expose fragile cells to strong forces that can damage the cells. Instead, the SkinGun™ gently delivers the CellMist™ Solution directly to the wound site using a positive-pressure air stream.

More specifically, the air stream does not ‘force’ the cells through a narrow aperture but rather only makes contact with the cells after they have left the patented SkinGun™ nozzle. The air stream ultra-gently ‘carries’ the cells to the wound site.

MedicalResearch.com: What should readers take away from your report?

Response: RenovaCare CellMist™ and SkinGun™ technologies herald the first generation of therapies capable of regenerating human organs using a patient’s own stem cells. Targeting the human body’s largest organ, the skin, RenovaCare technologies are the world’s most advanced systems of their kind.

At RenovaCare, we believe the ‘future of medicine’ has arrived with the development of this breakthrough stem cell technology.

MedicalResearch.com: Is there anything else you would like to add?

Response: Looking like a futuristic ‘phaser’ right out of Star Trek, surgeons will soon use a SkinGun™ to gently spray a patient’s own stem cells onto wounds and deep burns, regenerating skin in only a few days rather than the often year-long painful recovery process that patients endure today.

In 90 short minutes, a patient’s own stem cells are instantly isolated from a skin sample and ultra-gently sprayed on to wounds.

MedicalResearch.com: Thank you for your contribution to the MedicalResearch.com community.

Citation:

Note: Content is Not intended as medical advice.

Please consult your health care provider regarding your specific medical condition and questions.

[wysija_form id=”5″]

Last Updated on August 19, 2016 by Marie Benz MD FAAD